Product Description
Counterfeit medicines are fake medicines. These may be contaminated or contain wrong ingredients. It is estimated that globally, around 10% - 15% of medicines are counterfeit. This poses a threat to the global pharmaceuticals market. Anti-counterfeiting packaging is one of the measures that pharma majors are relying on. Pharmaceutical companies have been incorporating anti-counterfeit solutions with their product packages; of these, hologram, bar code, and water is common and considered as a conventional option for the same.
The Anti-Counterfeit Pharmaceutical Packaging market revenue was xx Million USD in 2019, grew to xx Million USD in 2023, and will reach xx Million USD in 2031, with a CAGR of xx during 2024-2031.
Considering the influence of COVID-19 on the global Anti-Counterfeit Pharmaceutical Packaging market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on analysis of market under COVID-19 and corresponding response policy in different regions.
This report also analyzes the strategies for different companies to deal with the impact of COVID-19 in detail to seek a path to recovery.
Under COVID-19 Outbreak, how the Anti-Counterfeit Pharmaceutical Packaging Industry will develop is also analyzed in detail in Chapter 1.8 of this report.
Major Players in Anti-Counterfeit Pharmaceutical Packaging market are:
Sicpa Holding Sa
Cfc international Corporation
Digimarc Corp
Alpvision
Avery Dennison Corporation
Impinj
3M
Alien Technology
Authentix
Aesica
Most important types of Anti-Counterfeit Pharmaceutical Packaging products covered in this report are:
Rfid
Security inks And Coatings
Security Printing & Graphics
Hologram
Mass Encoding
Others
Most widely used downstream fields of Anti-Counterfeit Pharmaceutical Packaging market covered in this report are:
Covert Features
Overt Features
Forensic Markers
Tamper Evidence
Track & Trace Technologies
Major Regions or countries covered in this report:
North America
Europe
China
Japan
Middle East and Africa
South America
India
South Korea
Southeast Asia
Others
In Chapter 3.4, the report provides analysis of the reasons behind price fluctuations.
In chapters 5, 6, and 7, the impact of COVID-19 on the different regions in both production and consumption end and SWOT analysis are pointed out.
In Chapters 8, the report presents company's recent development and strategies to deal with the impact of COVID-19.